Return On Equity of Immunome Inc. from 31 Dec 2020 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Summary
-
Immunome Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 31 Dec 2025.
- Immunome Inc. Return On Equity for the quarter ending 31 Dec 2025 was -58%, a 54% increase year-over-year.
- Immunome Inc. annual Return On Equity for 2025 was -58%, a 54% increase from 2024.
- Immunome Inc. annual Return On Equity for 2024 was -125%, a 56% increase from 2023.
- Immunome Inc. annual Return On Equity for 2023 was -286%, a 109% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
Immunome Inc. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -58% | +68% | +54% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -87% | +52% | +38% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -87% | +70% | +45% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -86% | +135% | +61% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -125% | +161% | +56% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -140% | +52% | +27% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -158% | +8.3% | +5% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -221% | -80% | -57% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -286% | -150% | -109% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -191% | -85% | -80% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -166% | -82% | -97% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -141% | -76% | -118% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -137% | -88% | -179% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -106% | -63% | -147% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -84% | +11% | +11% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -64% | -778% | -109% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -49% | -131% | -160% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -43% | 01 Jul 2021 | 30 Sep 2021 | ||
| Q2 2021 | -95% | 01 Apr 2021 | 30 Jun 2021 | ||
| Q1 2021 | 713% | 01 Jan 2021 | 31 Mar 2021 | ||
| Q4 2020 | 82% | 01 Oct 2020 | 31 Dec 2020 |
Immunome Inc. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -58% | +68% | +54% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -125% | +161% | +56% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | -286% | -150% | -109% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -137% | -88% | -179% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -49% | -131% | -160% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | 82% | 01 Jan 2020 | 31 Dec 2020 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.